MARKET OVERVIEW
Women's health is a field of medicine that focuses on the treatment and diagnosis of disorders that affect a woman's physical and mental health. It includes all treatments, medications, and surgical products for disorders affecting women. Due to biological, social, and behavioural differences, women's health and disease differ from men's. Various women disorders are, nutrition disorders, reproductive health disorders, menopause and menstrual cycle related disorders among others. The focus of women's health is on improved disease management and increasing or enhancing the overall health of the female population.
MARKET SCOPE
The "Global Women Health Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Women health market with detailed market segmentation by product type, treatment type, diagnosis, disease indication and end user. The report provides key statistics on the market status of the leading Women health market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
MARKET DYNAMICS
Drivers:
Restraints:
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Women health market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Women health market in these regions.
IMPACT OF COVID-19 ON WOMEN HEALTH MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
Speak to Analyst
MARKET PLAYERS
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Women health market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Women health market in these regions.
IMPACT OF COVID-19 ON WOMEN HEALTH MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the Women health market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Women health market are anticipated to lucrative growth opportunities in the future with the rising demand for Women health in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Women health market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Women's health is a field of medicine that focuses on the treatment and diagnosis of disorders that affect a woman's physical and mental health. It includes all treatments, medications, and surgical products for disorders affecting women. Due to biological, social, and behavioural differences, women's health and disease differ from men's. Various women disorders are, nutrition disorders, reproductive health disorders, menopause and menstrual cycle related disorders among others. The focus of women's health is on improved disease management and increasing or enhancing the overall health of the female population.
MARKET SCOPE
The "Global Women Health Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Women health market with detailed market segmentation by product type, treatment type, diagnosis, disease indication and end user. The report provides key statistics on the market status of the leading Women health market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on product type the market is segmented as, devices, drugs, pharmaceutical pipeline.
- Based on treatment type the market is segmented as, hormonal treatment, non-hormonal treatment, surgery.
- Based on the diagnosis the market is segmented as, diagnostic imaging test, biopsis, ovulation testing, others.
- Based on disease indication the market is segmented as, cancer, reproductive health, post- menopausal syndrome, urological disorders.
- Based on the end user the market is segmented as, hospitals, clinics, gynecology centers, research institutes, others.
MARKET DYNAMICS
Drivers:
- Increasing prevalence of gynecological disorders and other diseases affecting principally to women.
- Increasing awareness about women health.
- Increasing initiatives by government to promote women health and spreading awareness about women health.
- Rising R&D activities from pharmaceutical companies to develop and launch innovative therapies for management of women disorders.
- Presence of robust pipeline of therapeutic drugs.
Restraints:
- Whereas, possible side effects from drug therapies and lack of awarness about women health in some developing nations are expected to hamper market growth.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Women health market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Women health market in these regions.
IMPACT OF COVID-19 ON WOMEN HEALTH MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Women health market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Women health market in these regions.
IMPACT OF COVID-19 ON WOMEN HEALTH MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the Women health market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Women health market are anticipated to lucrative growth opportunities in the future with the rising demand for Women health in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Women health market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Eli Lilly and Company
- Agile Therapeutics
- Pfizer Inc
- Merck Sharp and Dohme Corp
- Ferring B.V
- Amgen Inc
- Mylan N.V. (Viatris)
- Abbott
- F. Hoffmann-La Roche Ltd
- Blairex Laboratories, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Women Health Market - By Product Type
1.3.2 Women Health Market - By Treatment Type
1.3.3 Women Health Market - By Diagnosis
1.3.4 Women Health Market - By Disease Indication
1.3.5 Women Health Market - By End-Users
1.3.6 Women Health Market - By Region
1.3.6.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. WOMEN HEALTH MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. WOMEN HEALTH MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. WOMEN HEALTH MARKET - GLOBAL MARKET ANALYSIS
6.1. WOMEN HEALTH - GLOBAL MARKET OVERVIEW
6.2. WOMEN HEALTH - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. WOMEN HEALTH MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. DEVICES
7.3.1. Overview
7.3.2. Devices Market Forecast and Analysis
7.3.3. Intra Uterine Devices Market
7.3.3.1. Overview
7.3.3.2. Intra Uterine Devices Market Forecast and Analysis
7.3.4. Vaginal Rings Market
7.3.4.1. Overview
7.3.4.2. Vaginal Rings Market Forecast and Analysis
7.3.5. Implants Market
7.3.5.1. Overview
7.3.5.2. Implants Market Forecast and Analysis
7.3.6. Female Condoms Market
7.3.6.1. Overview
7.3.6.2. Female Condoms Market Forecast and Analysis
7.4. DRUGS
7.4.1. Overview
7.4.2. Drugs Market Forecast and Analysis
7.4.3. Menopause Drugs Market
7.4.3.1. Overview
7.4.3.2. Menopause Drugs Market Forecast and Analysis
7.4.4. Menopausal Hot Flashes Drugs Market
7.4.4.1. Overview
7.4.4.2. Menopausal Hot Flashes Drugs Market Forecast and Analysis
7.5. PHARMACEUTICAL PIPELINE
7.5.1. Overview
7.5.2. Pharmaceutical Pipeline Market Forecast and Analysis
8. WOMEN HEALTH MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT TYPE
8.1. OVERVIEW
8.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
8.3. HORMONAL TREATMENT
8.3.1. Overview
8.3.2. Hormonal Treatment Market Forecast and Analysis
8.3.3. Estrogen Therapy Market
8.3.3.1. Overview
8.3.3.2. Estrogen Therapy Market Forecast and Analysis
8.3.4. Progestin Therapy Market
8.3.4.1. Overview
8.3.4.2. Progestin Therapy Market Forecast and Analysis
8.3.5. Combination Therapy Market
8.3.5.1. Overview
8.3.5.2. Combination Therapy Market Forecast and Analysis
8.3.6. Thyroid Replacement Therapy Market
8.3.6.1. Overview
8.3.6.2. Thyroid Replacement Therapy Market Forecast and Analysis
8.3.7. Parathyroid Hormone Therapy Market
8.3.7.1. Overview
8.3.7.2. Parathyroid Hormone Therapy Market Forecast and Analysis
8.4. NON-HORMONAL TREATMENT
8.4.1. Overview
8.4.2. Non-Hormonal Treatment Market Forecast and Analysis
8.4.3. Targeted Therapy Market
8.4.3.1. Overview
8.4.3.2. Targeted Therapy Market Forecast and Analysis
8.4.4. Drugs Market
8.4.4.1. Overview
8.4.4.2. Drugs Market Forecast and Analysis
8.4.5. Antibiotics Market
8.4.5.1. Overview
8.4.5.2. Antibiotics Market Forecast and Analysis
8.4.6. Bisphosphonates Market
8.4.6.1. Overview
8.4.6.2. Bisphosphonates Market Forecast and Analysis
8.4.7. Others Market
8.4.7.1. Overview
8.4.7.2. Others Market Forecast and Analysis
8.5. SURGERIES
8.5.1. Overview
8.5.2. Surgeries Market Forecast and Analysis
9. WOMEN HEALTH MARKET - REVENUE AND FORECASTS TO 2028 - DIAGNOSIS
9.1. OVERVIEW
9.2. DIAGNOSIS MARKET FORECASTS AND ANALYSIS
9.3. BONE DENSITOMETRY
9.3.1. Overview
9.3.2. Bone Densitometry Market Forecast and Analysis
9.4. DIAGNOSTIC IMAGING TESTS
9.4.1. Overview
9.4.2. Diagnostic Imaging Tests Market Forecast and Analysis
9.5. BIOPSIES
9.5.1. Overview
9.5.2. Biopsies Market Forecast and Analysis
9.6. OVULATION TESTING
9.6.1. Overview
9.6.2. Ovulation Testing Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. WOMEN HEALTH MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE INDICATION
10.1. OVERVIEW
10.2. DISEASE INDICATION MARKET FORECASTS AND ANALYSIS
10.3. CANCER
10.3.1. Overview
10.3.2. Cancer Market Forecast and Analysis
10.3.3. Breast Cancer Market
10.3.3.1. Overview
10.3.3.2. Breast Cancer Market Forecast and Analysis
10.3.4. Cervical Cancer Market
10.3.4.1. Overview
10.3.4.2. Cervical Cancer Market Forecast and Analysis
10.3.5. Ovarian Cancer Market
10.3.5.1. Overview
10.3.5.2. Ovarian Cancer Market Forecast and Analysis
10.4. REPRODUCTIVE HEALTH
10.4.1. Overview
10.4.2. Reproductive Health Market Forecast and Analysis
10.4.3. Infertility Market
10.4.3.1. Overview
10.4.3.2. Infertility Market Forecast and Analysis
10.4.4. Endometriosis Market
10.4.4.1. Overview
10.4.4.2. Endometriosis Market Forecast and Analysis
10.4.5. PCOS Market
10.4.5.1. Overview
10.4.5.2. PCOS Market Forecast and Analysis
10.5. POST-MENOPAUSAL SYNDROME
10.5.1. Overview
10.5.2. Post-Menopausal Syndrome Market Forecast and Analysis
10.5.3. Osteoporosis Market
10.5.3.1. Overview
10.5.3.2. Osteoporosis Market Forecast and Analysis
10.5.4. Menopause Market
10.5.4.1. Overview
10.5.4.2. Menopause Market Forecast and Analysis
10.6. UROLOGICAL DISORDERS
10.6.1. Overview
10.6.2. Urological Disorders Market Forecast and Analysis
10.6.3. Urinary Incontinence Market
10.6.3.1. Overview
10.6.3.2. Urinary Incontinence Market Forecast and Analysis
10.6.4. Uterine Fibroid Market
10.6.4.1. Overview
10.6.4.2. Uterine Fibroid Market Forecast and Analysis
10.6.5. Urinary Tract Infections (UTIs) Market
10.6.5.1. Overview
10.6.5.2. Urinary Tract Infections (UTIs) Market Forecast and Analysis
11. WOMEN HEALTH MARKET - REVENUE AND FORECASTS TO 2028 - END-USERS
11.1. OVERVIEW
11.2. END-USERS MARKET FORECASTS AND ANALYSIS
11.3. HOSPITAL AND CLINICS
11.3.1. Overview
11.3.2. Hospital and clinics Market Forecast and Analysis
11.4. GYNECOLOGY CENTERS
11.4.1. Overview
11.4.2. Gynecology centers Market Forecast and Analysis
11.5. RESEARCH INSTITUTES
11.5.1. Overview
11.5.2. Research Institutes Market Forecast and Analysis
11.6. OTHERS
11.6.1. Overview
11.6.2. Others Market Forecast and Analysis
12. WOMEN HEALTH MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America Women Health Market Overview
12.1.2 North America Women Health Market Forecasts and Analysis
12.1.3 North America Women Health Market Forecasts and Analysis - By Product Type
12.1.4 North America Women Health Market Forecasts and Analysis - By Treatment Type
12.1.5 North America Women Health Market Forecasts and Analysis - By Diagnosis
12.1.6 North America Women Health Market Forecasts and Analysis - By Disease Indication
12.1.7 North America Women Health Market Forecasts and Analysis - By End-Users
12.1.8 North America Women Health Market Forecasts and Analysis - By Countries
12.1.8.1 United States Women Health Market
12.1.8.1.1 United States Women Health Market by Product Type
12.1.8.1.2 United States Women Health Market by Treatment Type
12.1.8.1.3 United States Women Health Market by Diagnosis
12.1.8.1.4 United States Women Health Market by Disease Indication
12.1.8.1.5 United States Women Health Market by End-Users
12.1.8.2 Canada Women Health Market
12.1.8.2.1 Canada Women Health Market by Product Type
12.1.8.2.2 Canada Women Health Market by Treatment Type
12.1.8.2.3 Canada Women Health Market by Diagnosis
12.1.8.2.4 Canada Women Health Market by Disease Indication
12.1.8.2.5 Canada Women Health Market by End-Users
12.1.8.3 Mexico Women Health Market
12.1.8.3.1 Mexico Women Health Market by Product Type
12.1.8.3.2 Mexico Women Health Market by Treatment Type
12.1.8.3.3 Mexico Women Health Market by Diagnosis
12.1.8.3.4 Mexico Women Health Market by Disease Indication
12.1.8.3.5 Mexico Women Health Market by End-Users
12.2. EUROPE
12.2.1 Europe Women Health Market Overview
12.2.2 Europe Women Health Market Forecasts and Analysis
12.2.3 Europe Women Health Market Forecasts and Analysis - By Product Type
12.2.4 Europe Women Health Market Forecasts and Analysis - By Treatment Type
12.2.5 Europe Women Health Market Forecasts and Analysis - By Diagnosis
12.2.6 Europe Women Health Market Forecasts and Analysis - By Disease Indication
12.2.7 Europe Women Health Market Forecasts and Analysis - By End-Users
12.2.8 Europe Women Health Market Forecasts and Analysis - By Countries
12.2.8.1 Germany Women Health Market
12.2.8.1.1 Germany Women Health Market by Product Type
12.2.8.1.2 Germany Women Health Market by Treatment Type
12.2.8.1.3 Germany Women Health Market by Diagnosis
12.2.8.1.4 Germany Women Health Market by Disease Indication
12.2.8.1.5 Germany Women Health Market by End-Users
12.2.8.2 France Women Health Market
12.2.8.2.1 France Women Health Market by Product Type
12.2.8.2.2 France Women Health Market by Treatment Type
12.2.8.2.3 France Women Health Market by Diagnosis
12.2.8.2.4 France Women Health Market by Disease Indication
12.2.8.2.5 France Women Health Market by End-Users
12.2.8.3 Italy Women Health Market
12.2.8.3.1 Italy Women Health Market by Product Type
12.2.8.3.2 Italy Women Health Market by Treatment Type
12.2.8.3.3 Italy Women Health Market by Diagnosis
12.2.8.3.4 Italy Women Health Market by Disease Indication
12.2.8.3.5 Italy Women Health Market by End-Users
12.2.8.4 Spain Women Health Market
12.2.8.4.1 Spain Women Health Market by Product Type
12.2.8.4.2 Spain Women Health Market by Treatment Type
12.2.8.4.3 Spain Women Health Market by Diagnosis
12.2.8.4.4 Spain Women Health Market by Disease Indication
12.2.8.4.5 Spain Women Health Market by End-Users
12.2.8.5 United Kingdom Women Health Market
12.2.8.5.1 United Kingdom Women Health Market by Product Type
12.2.8.5.2 United Kingdom Women Health Market by Treatment Type
12.2.8.5.3 United Kingdom Women Health Market by Diagnosis
12.2.8.5.4 United Kingdom Women Health Market by Disease Indication
12.2.8.5.5 United Kingdom Women Health Market by End-Users
12.2.8.6 Rest of Europe Women Health Market
12.2.8.6.1 Rest of Europe Women Health Market by Product Type
12.2.8.6.2 Rest of Europe Women Health Market by Treatment Type
12.2.8.6.3 Rest of Europe Women Health Market by Diagnosis
12.2.8.6.4 Rest of Europe Women Health Market by Disease Indication
12.2.8.6.5 Rest of Europe Women Health Market by End-Users
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific Women Health Market Overview
12.3.2 Asia-Pacific Women Health Market Forecasts and Analysis
12.3.3 Asia-Pacific Women Health Market Forecasts and Analysis - By Product Type
12.3.4 Asia-Pacific Women Health Market Forecasts and Analysis - By Treatment Type
12.3.5 Asia-Pacific Women Health Market Forecasts and Analysis - By Diagnosis
12.3.6 Asia-Pacific Women Health Market Forecasts and Analysis - By Disease Indication
12.3.7 Asia-Pacific Women Health Market Forecasts and Analysis - By End-Users
12.3.8 Asia-Pacific Women Health Market Forecasts and Analysis - By Countries
12.3.8.1 Australia Women Health Market
12.3.8.1.1 Australia Women Health Market by Product Type
12.3.8.1.2 Australia Women Health Market by Treatment Type
12.3.8.1.3 Australia Women Health Market by Diagnosis
12.3.8.1.4 Australia Women Health Market by Disease Indication
12.3.8.1.5 Australia Women Health Market by End-Users
12.3.8.2 China Women Health Market
12.3.8.2.1 China Women Health Market by Product Type
12.3.8.2.2 China Women Health Market by Treatment Type
12.3.8.2.3 China Women Health Market by Diagnosis
12.3.8.2.4 China Women Health Market by Disease Indication
12.3.8.2.5 China Women Health Market by End-Users
12.3.8.3 India Women Health Market
12.3.8.3.1 India Women Health Market by Product Type
12.3.8.3.2 India Women Health Market by Treatment Type
12.3.8.3.3 India Women Health Market by Diagnosis
12.3.8.3.4 India Women Health Market by Disease Indication
12.3.8.3.5 India Women Health Market by End-Users
12.3.8.4 Japan Women Health Market
12.3.8.4.1 Japan Women Health Market by Product Type
12.3.8.4.2 Japan Women Health Market by Treatment Type
12.3.8.4.3 Japan Women Health Market by Diagnosis
12.3.8.4.4 Japan Women Health Market by Disease Indication
12.3.8.4.5 Japan Women Health Market by End-Users
12.3.8.5 South Korea Women Health Market
12.3.8.5.1 South Korea Women Health Market by Product Type
12.3.8.5.2 South Korea Women Health Market by Treatment Type
12.3.8.5.3 South Korea Women Health Market by Diagnosis
12.3.8.5.4 South Korea Women Health Market by Disease Indication
12.3.8.5.5 South Korea Women Health Market by End-Users
12.3.8.6 Rest of Asia-Pacific Women Health Market
12.3.8.6.1 Rest of Asia-Pacific Women Health Market by Product Type
12.3.8.6.2 Rest of Asia-Pacific Women Health Market by Treatment Type
12.3.8.6.3 Rest of Asia-Pacific Women Health Market by Diagnosis
12.3.8.6.4 Rest of Asia-Pacific Women Health Market by Disease Indication
12.3.8.6.5 Rest of Asia-Pacific Women Health Market by End-Users
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa Women Health Market Overview
12.4.2 Middle East and Africa Women Health Market Forecasts and Analysis
12.4.3 Middle East and Africa Women Health Market Forecasts and Analysis - By Product Type
12.4.4 Middle East and Africa Women Health Market Forecasts and Analysis - By Treatment Type
12.4.5 Middle East and Africa Women Health Market Forecasts and Analysis - By Diagnosis
12.4.6 Middle East and Africa Women Health Market Forecasts and Analysis - By Disease Indication
12.4.7 Middle East and Africa Women Health Market Forecasts and Analysis - By End-Users
12.4.8 Middle East and Africa Women Health Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa Women Health Market
12.4.8.1.1 South Africa Women Health Market by Product Type
12.4.8.1.2 South Africa Women Health Market by Treatment Type
12.4.8.1.3 South Africa Women Health Market by Diagnosis
12.4.8.1.4 South Africa Women Health Market by Disease Indication
12.4.8.1.5 South Africa Women Health Market by End-Users
12.4.8.2 Saudi Arabia Women Health Market
12.4.8.2.1 Saudi Arabia Women Health Market by Product Type
12.4.8.2.2 Saudi Arabia Women Health Market by Treatment Type
12.4.8.2.3 Saudi Arabia Women Health Market by Diagnosis
12.4.8.2.4 Saudi Arabia Women Health Market by Disease Indication
12.4.8.2.5 Saudi Arabia Women Health Market by End-Users
12.4.8.3 U.A.E Women Health Market
12.4.8.3.1 U.A.E Women Health Market by Product Type
12.4.8.3.2 U.A.E Women Health Market by Treatment Type
12.4.8.3.3 U.A.E Women Health Market by Diagnosis
12.4.8.3.4 U.A.E Women Health Market by Disease Indication
12.4.8.3.5 U.A.E Women Health Market by End-Users
12.4.8.4 Rest of Middle East and Africa Women Health Market
12.4.8.4.1 Rest of Middle East and Africa Women Health Market by Product Type
12.4.8.4.2 Rest of Middle East and Africa Women Health Market by Treatment Type
12.4.8.4.3 Rest of Middle East and Africa Women Health Market by Diagnosis
12.4.8.4.4 Rest of Middle East and Africa Women Health Market by Disease Indication
12.4.8.4.5 Rest of Middle East and Africa Women Health Market by End-Users
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America Women Health Market Overview
12.5.2 South and Central America Women Health Market Forecasts and Analysis
12.5.3 South and Central America Women Health Market Forecasts and Analysis - By Product Type
12.5.4 South and Central America Women Health Market Forecasts and Analysis - By Treatment Type
12.5.5 South and Central America Women Health Market Forecasts and Analysis - By Diagnosis
12.5.6 South and Central America Women Health Market Forecasts and Analysis - By Disease Indication
12.5.7 South and Central America Women Health Market Forecasts and Analysis - By End-Users
12.5.8 South and Central America Women Health Market Forecasts and Analysis - By Countries
12.5.8.1 Brazil Women Health Market
12.5.8.1.1 Brazil Women Health Market by Product Type
12.5.8.1.2 Brazil Women Health Market by Treatment Type
12.5.8.1.3 Brazil Women Health Market by Diagnosis
12.5.8.1.4 Brazil Women Health Market by Disease Indication
12.5.8.1.5 Brazil Women Health Market by End-Users
12.5.8.2 Argentina Women Health Market
12.5.8.2.1 Argentina Women Health Market by Product Type
12.5.8.2.2 Argentina Women Health Market by Treatment Type
12.5.8.2.3 Argentina Women Health Market by Diagnosis
12.5.8.2.4 Argentina Women Health Market by Disease Indication
12.5.8.2.5 Argentina Women Health Market by End-Users
12.5.8.3 Rest of South and Central America Women Health Market
12.5.8.3.1 Rest of South and Central America Women Health Market by Product Type
12.5.8.3.2 Rest of South and Central America Women Health Market by Treatment Type
12.5.8.3.3 Rest of South and Central America Women Health Market by Diagnosis
12.5.8.3.4 Rest of South and Central America Women Health Market by Disease Indication
12.5.8.3.5 Rest of South and Central America Women Health Market by End-Users
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. WOMEN HEALTH MARKET, KEY COMPANY PROFILES
14.1. ELI LILLY AND COMPANY
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. AGILE THERAPEUTICS
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. PFIZER INC
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. MERCK SHARP AND DOHME CORP
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. FERRING B.V
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. AMGEN INC
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. MYLAN N.V. ( VIATRIS)
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. ABBOTT
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. F. HOFFMANN-LA ROCHE LTD
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. BLAIREX LABORATORIES, INC.
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Women Health Market - By Product Type
1.3.2 Women Health Market - By Treatment Type
1.3.3 Women Health Market - By Diagnosis
1.3.4 Women Health Market - By Disease Indication
1.3.5 Women Health Market - By End-Users
1.3.6 Women Health Market - By Region
1.3.6.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. WOMEN HEALTH MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. WOMEN HEALTH MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. WOMEN HEALTH MARKET - GLOBAL MARKET ANALYSIS
6.1. WOMEN HEALTH - GLOBAL MARKET OVERVIEW
6.2. WOMEN HEALTH - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. WOMEN HEALTH MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. DEVICES
7.3.1. Overview
7.3.2. Devices Market Forecast and Analysis
7.3.3. Intra Uterine Devices Market
7.3.3.1. Overview
7.3.3.2. Intra Uterine Devices Market Forecast and Analysis
7.3.4. Vaginal Rings Market
7.3.4.1. Overview
7.3.4.2. Vaginal Rings Market Forecast and Analysis
7.3.5. Implants Market
7.3.5.1. Overview
7.3.5.2. Implants Market Forecast and Analysis
7.3.6. Female Condoms Market
7.3.6.1. Overview
7.3.6.2. Female Condoms Market Forecast and Analysis
7.4. DRUGS
7.4.1. Overview
7.4.2. Drugs Market Forecast and Analysis
7.4.3. Menopause Drugs Market
7.4.3.1. Overview
7.4.3.2. Menopause Drugs Market Forecast and Analysis
7.4.4. Menopausal Hot Flashes Drugs Market
7.4.4.1. Overview
7.4.4.2. Menopausal Hot Flashes Drugs Market Forecast and Analysis
7.5. PHARMACEUTICAL PIPELINE
7.5.1. Overview
7.5.2. Pharmaceutical Pipeline Market Forecast and Analysis
8. WOMEN HEALTH MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT TYPE
8.1. OVERVIEW
8.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
8.3. HORMONAL TREATMENT
8.3.1. Overview
8.3.2. Hormonal Treatment Market Forecast and Analysis
8.3.3. Estrogen Therapy Market
8.3.3.1. Overview
8.3.3.2. Estrogen Therapy Market Forecast and Analysis
8.3.4. Progestin Therapy Market
8.3.4.1. Overview
8.3.4.2. Progestin Therapy Market Forecast and Analysis
8.3.5. Combination Therapy Market
8.3.5.1. Overview
8.3.5.2. Combination Therapy Market Forecast and Analysis
8.3.6. Thyroid Replacement Therapy Market
8.3.6.1. Overview
8.3.6.2. Thyroid Replacement Therapy Market Forecast and Analysis
8.3.7. Parathyroid Hormone Therapy Market
8.3.7.1. Overview
8.3.7.2. Parathyroid Hormone Therapy Market Forecast and Analysis
8.4. NON-HORMONAL TREATMENT
8.4.1. Overview
8.4.2. Non-Hormonal Treatment Market Forecast and Analysis
8.4.3. Targeted Therapy Market
8.4.3.1. Overview
8.4.3.2. Targeted Therapy Market Forecast and Analysis
8.4.4. Drugs Market
8.4.4.1. Overview
8.4.4.2. Drugs Market Forecast and Analysis
8.4.5. Antibiotics Market
8.4.5.1. Overview
8.4.5.2. Antibiotics Market Forecast and Analysis
8.4.6. Bisphosphonates Market
8.4.6.1. Overview
8.4.6.2. Bisphosphonates Market Forecast and Analysis
8.4.7. Others Market
8.4.7.1. Overview
8.4.7.2. Others Market Forecast and Analysis
8.5. SURGERIES
8.5.1. Overview
8.5.2. Surgeries Market Forecast and Analysis
9. WOMEN HEALTH MARKET - REVENUE AND FORECASTS TO 2028 - DIAGNOSIS
9.1. OVERVIEW
9.2. DIAGNOSIS MARKET FORECASTS AND ANALYSIS
9.3. BONE DENSITOMETRY
9.3.1. Overview
9.3.2. Bone Densitometry Market Forecast and Analysis
9.4. DIAGNOSTIC IMAGING TESTS
9.4.1. Overview
9.4.2. Diagnostic Imaging Tests Market Forecast and Analysis
9.5. BIOPSIES
9.5.1. Overview
9.5.2. Biopsies Market Forecast and Analysis
9.6. OVULATION TESTING
9.6.1. Overview
9.6.2. Ovulation Testing Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. WOMEN HEALTH MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE INDICATION
10.1. OVERVIEW
10.2. DISEASE INDICATION MARKET FORECASTS AND ANALYSIS
10.3. CANCER
10.3.1. Overview
10.3.2. Cancer Market Forecast and Analysis
10.3.3. Breast Cancer Market
10.3.3.1. Overview
10.3.3.2. Breast Cancer Market Forecast and Analysis
10.3.4. Cervical Cancer Market
10.3.4.1. Overview
10.3.4.2. Cervical Cancer Market Forecast and Analysis
10.3.5. Ovarian Cancer Market
10.3.5.1. Overview
10.3.5.2. Ovarian Cancer Market Forecast and Analysis
10.4. REPRODUCTIVE HEALTH
10.4.1. Overview
10.4.2. Reproductive Health Market Forecast and Analysis
10.4.3. Infertility Market
10.4.3.1. Overview
10.4.3.2. Infertility Market Forecast and Analysis
10.4.4. Endometriosis Market
10.4.4.1. Overview
10.4.4.2. Endometriosis Market Forecast and Analysis
10.4.5. PCOS Market
10.4.5.1. Overview
10.4.5.2. PCOS Market Forecast and Analysis
10.5. POST-MENOPAUSAL SYNDROME
10.5.1. Overview
10.5.2. Post-Menopausal Syndrome Market Forecast and Analysis
10.5.3. Osteoporosis Market
10.5.3.1. Overview
10.5.3.2. Osteoporosis Market Forecast and Analysis
10.5.4. Menopause Market
10.5.4.1. Overview
10.5.4.2. Menopause Market Forecast and Analysis
10.6. UROLOGICAL DISORDERS
10.6.1. Overview
10.6.2. Urological Disorders Market Forecast and Analysis
10.6.3. Urinary Incontinence Market
10.6.3.1. Overview
10.6.3.2. Urinary Incontinence Market Forecast and Analysis
10.6.4. Uterine Fibroid Market
10.6.4.1. Overview
10.6.4.2. Uterine Fibroid Market Forecast and Analysis
10.6.5. Urinary Tract Infections (UTIs) Market
10.6.5.1. Overview
10.6.5.2. Urinary Tract Infections (UTIs) Market Forecast and Analysis
11. WOMEN HEALTH MARKET - REVENUE AND FORECASTS TO 2028 - END-USERS
11.1. OVERVIEW
11.2. END-USERS MARKET FORECASTS AND ANALYSIS
11.3. HOSPITAL AND CLINICS
11.3.1. Overview
11.3.2. Hospital and clinics Market Forecast and Analysis
11.4. GYNECOLOGY CENTERS
11.4.1. Overview
11.4.2. Gynecology centers Market Forecast and Analysis
11.5. RESEARCH INSTITUTES
11.5.1. Overview
11.5.2. Research Institutes Market Forecast and Analysis
11.6. OTHERS
11.6.1. Overview
11.6.2. Others Market Forecast and Analysis
12. WOMEN HEALTH MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America Women Health Market Overview
12.1.2 North America Women Health Market Forecasts and Analysis
12.1.3 North America Women Health Market Forecasts and Analysis - By Product Type
12.1.4 North America Women Health Market Forecasts and Analysis - By Treatment Type
12.1.5 North America Women Health Market Forecasts and Analysis - By Diagnosis
12.1.6 North America Women Health Market Forecasts and Analysis - By Disease Indication
12.1.7 North America Women Health Market Forecasts and Analysis - By End-Users
12.1.8 North America Women Health Market Forecasts and Analysis - By Countries
12.1.8.1 United States Women Health Market
12.1.8.1.1 United States Women Health Market by Product Type
12.1.8.1.2 United States Women Health Market by Treatment Type
12.1.8.1.3 United States Women Health Market by Diagnosis
12.1.8.1.4 United States Women Health Market by Disease Indication
12.1.8.1.5 United States Women Health Market by End-Users
12.1.8.2 Canada Women Health Market
12.1.8.2.1 Canada Women Health Market by Product Type
12.1.8.2.2 Canada Women Health Market by Treatment Type
12.1.8.2.3 Canada Women Health Market by Diagnosis
12.1.8.2.4 Canada Women Health Market by Disease Indication
12.1.8.2.5 Canada Women Health Market by End-Users
12.1.8.3 Mexico Women Health Market
12.1.8.3.1 Mexico Women Health Market by Product Type
12.1.8.3.2 Mexico Women Health Market by Treatment Type
12.1.8.3.3 Mexico Women Health Market by Diagnosis
12.1.8.3.4 Mexico Women Health Market by Disease Indication
12.1.8.3.5 Mexico Women Health Market by End-Users
12.2. EUROPE
12.2.1 Europe Women Health Market Overview
12.2.2 Europe Women Health Market Forecasts and Analysis
12.2.3 Europe Women Health Market Forecasts and Analysis - By Product Type
12.2.4 Europe Women Health Market Forecasts and Analysis - By Treatment Type
12.2.5 Europe Women Health Market Forecasts and Analysis - By Diagnosis
12.2.6 Europe Women Health Market Forecasts and Analysis - By Disease Indication
12.2.7 Europe Women Health Market Forecasts and Analysis - By End-Users
12.2.8 Europe Women Health Market Forecasts and Analysis - By Countries
12.2.8.1 Germany Women Health Market
12.2.8.1.1 Germany Women Health Market by Product Type
12.2.8.1.2 Germany Women Health Market by Treatment Type
12.2.8.1.3 Germany Women Health Market by Diagnosis
12.2.8.1.4 Germany Women Health Market by Disease Indication
12.2.8.1.5 Germany Women Health Market by End-Users
12.2.8.2 France Women Health Market
12.2.8.2.1 France Women Health Market by Product Type
12.2.8.2.2 France Women Health Market by Treatment Type
12.2.8.2.3 France Women Health Market by Diagnosis
12.2.8.2.4 France Women Health Market by Disease Indication
12.2.8.2.5 France Women Health Market by End-Users
12.2.8.3 Italy Women Health Market
12.2.8.3.1 Italy Women Health Market by Product Type
12.2.8.3.2 Italy Women Health Market by Treatment Type
12.2.8.3.3 Italy Women Health Market by Diagnosis
12.2.8.3.4 Italy Women Health Market by Disease Indication
12.2.8.3.5 Italy Women Health Market by End-Users
12.2.8.4 Spain Women Health Market
12.2.8.4.1 Spain Women Health Market by Product Type
12.2.8.4.2 Spain Women Health Market by Treatment Type
12.2.8.4.3 Spain Women Health Market by Diagnosis
12.2.8.4.4 Spain Women Health Market by Disease Indication
12.2.8.4.5 Spain Women Health Market by End-Users
12.2.8.5 United Kingdom Women Health Market
12.2.8.5.1 United Kingdom Women Health Market by Product Type
12.2.8.5.2 United Kingdom Women Health Market by Treatment Type
12.2.8.5.3 United Kingdom Women Health Market by Diagnosis
12.2.8.5.4 United Kingdom Women Health Market by Disease Indication
12.2.8.5.5 United Kingdom Women Health Market by End-Users
12.2.8.6 Rest of Europe Women Health Market
12.2.8.6.1 Rest of Europe Women Health Market by Product Type
12.2.8.6.2 Rest of Europe Women Health Market by Treatment Type
12.2.8.6.3 Rest of Europe Women Health Market by Diagnosis
12.2.8.6.4 Rest of Europe Women Health Market by Disease Indication
12.2.8.6.5 Rest of Europe Women Health Market by End-Users
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific Women Health Market Overview
12.3.2 Asia-Pacific Women Health Market Forecasts and Analysis
12.3.3 Asia-Pacific Women Health Market Forecasts and Analysis - By Product Type
12.3.4 Asia-Pacific Women Health Market Forecasts and Analysis - By Treatment Type
12.3.5 Asia-Pacific Women Health Market Forecasts and Analysis - By Diagnosis
12.3.6 Asia-Pacific Women Health Market Forecasts and Analysis - By Disease Indication
12.3.7 Asia-Pacific Women Health Market Forecasts and Analysis - By End-Users
12.3.8 Asia-Pacific Women Health Market Forecasts and Analysis - By Countries
12.3.8.1 Australia Women Health Market
12.3.8.1.1 Australia Women Health Market by Product Type
12.3.8.1.2 Australia Women Health Market by Treatment Type
12.3.8.1.3 Australia Women Health Market by Diagnosis
12.3.8.1.4 Australia Women Health Market by Disease Indication
12.3.8.1.5 Australia Women Health Market by End-Users
12.3.8.2 China Women Health Market
12.3.8.2.1 China Women Health Market by Product Type
12.3.8.2.2 China Women Health Market by Treatment Type
12.3.8.2.3 China Women Health Market by Diagnosis
12.3.8.2.4 China Women Health Market by Disease Indication
12.3.8.2.5 China Women Health Market by End-Users
12.3.8.3 India Women Health Market
12.3.8.3.1 India Women Health Market by Product Type
12.3.8.3.2 India Women Health Market by Treatment Type
12.3.8.3.3 India Women Health Market by Diagnosis
12.3.8.3.4 India Women Health Market by Disease Indication
12.3.8.3.5 India Women Health Market by End-Users
12.3.8.4 Japan Women Health Market
12.3.8.4.1 Japan Women Health Market by Product Type
12.3.8.4.2 Japan Women Health Market by Treatment Type
12.3.8.4.3 Japan Women Health Market by Diagnosis
12.3.8.4.4 Japan Women Health Market by Disease Indication
12.3.8.4.5 Japan Women Health Market by End-Users
12.3.8.5 South Korea Women Health Market
12.3.8.5.1 South Korea Women Health Market by Product Type
12.3.8.5.2 South Korea Women Health Market by Treatment Type
12.3.8.5.3 South Korea Women Health Market by Diagnosis
12.3.8.5.4 South Korea Women Health Market by Disease Indication
12.3.8.5.5 South Korea Women Health Market by End-Users
12.3.8.6 Rest of Asia-Pacific Women Health Market
12.3.8.6.1 Rest of Asia-Pacific Women Health Market by Product Type
12.3.8.6.2 Rest of Asia-Pacific Women Health Market by Treatment Type
12.3.8.6.3 Rest of Asia-Pacific Women Health Market by Diagnosis
12.3.8.6.4 Rest of Asia-Pacific Women Health Market by Disease Indication
12.3.8.6.5 Rest of Asia-Pacific Women Health Market by End-Users
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa Women Health Market Overview
12.4.2 Middle East and Africa Women Health Market Forecasts and Analysis
12.4.3 Middle East and Africa Women Health Market Forecasts and Analysis - By Product Type
12.4.4 Middle East and Africa Women Health Market Forecasts and Analysis - By Treatment Type
12.4.5 Middle East and Africa Women Health Market Forecasts and Analysis - By Diagnosis
12.4.6 Middle East and Africa Women Health Market Forecasts and Analysis - By Disease Indication
12.4.7 Middle East and Africa Women Health Market Forecasts and Analysis - By End-Users
12.4.8 Middle East and Africa Women Health Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa Women Health Market
12.4.8.1.1 South Africa Women Health Market by Product Type
12.4.8.1.2 South Africa Women Health Market by Treatment Type
12.4.8.1.3 South Africa Women Health Market by Diagnosis
12.4.8.1.4 South Africa Women Health Market by Disease Indication
12.4.8.1.5 South Africa Women Health Market by End-Users
12.4.8.2 Saudi Arabia Women Health Market
12.4.8.2.1 Saudi Arabia Women Health Market by Product Type
12.4.8.2.2 Saudi Arabia Women Health Market by Treatment Type
12.4.8.2.3 Saudi Arabia Women Health Market by Diagnosis
12.4.8.2.4 Saudi Arabia Women Health Market by Disease Indication
12.4.8.2.5 Saudi Arabia Women Health Market by End-Users
12.4.8.3 U.A.E Women Health Market
12.4.8.3.1 U.A.E Women Health Market by Product Type
12.4.8.3.2 U.A.E Women Health Market by Treatment Type
12.4.8.3.3 U.A.E Women Health Market by Diagnosis
12.4.8.3.4 U.A.E Women Health Market by Disease Indication
12.4.8.3.5 U.A.E Women Health Market by End-Users
12.4.8.4 Rest of Middle East and Africa Women Health Market
12.4.8.4.1 Rest of Middle East and Africa Women Health Market by Product Type
12.4.8.4.2 Rest of Middle East and Africa Women Health Market by Treatment Type
12.4.8.4.3 Rest of Middle East and Africa Women Health Market by Diagnosis
12.4.8.4.4 Rest of Middle East and Africa Women Health Market by Disease Indication
12.4.8.4.5 Rest of Middle East and Africa Women Health Market by End-Users
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America Women Health Market Overview
12.5.2 South and Central America Women Health Market Forecasts and Analysis
12.5.3 South and Central America Women Health Market Forecasts and Analysis - By Product Type
12.5.4 South and Central America Women Health Market Forecasts and Analysis - By Treatment Type
12.5.5 South and Central America Women Health Market Forecasts and Analysis - By Diagnosis
12.5.6 South and Central America Women Health Market Forecasts and Analysis - By Disease Indication
12.5.7 South and Central America Women Health Market Forecasts and Analysis - By End-Users
12.5.8 South and Central America Women Health Market Forecasts and Analysis - By Countries
12.5.8.1 Brazil Women Health Market
12.5.8.1.1 Brazil Women Health Market by Product Type
12.5.8.1.2 Brazil Women Health Market by Treatment Type
12.5.8.1.3 Brazil Women Health Market by Diagnosis
12.5.8.1.4 Brazil Women Health Market by Disease Indication
12.5.8.1.5 Brazil Women Health Market by End-Users
12.5.8.2 Argentina Women Health Market
12.5.8.2.1 Argentina Women Health Market by Product Type
12.5.8.2.2 Argentina Women Health Market by Treatment Type
12.5.8.2.3 Argentina Women Health Market by Diagnosis
12.5.8.2.4 Argentina Women Health Market by Disease Indication
12.5.8.2.5 Argentina Women Health Market by End-Users
12.5.8.3 Rest of South and Central America Women Health Market
12.5.8.3.1 Rest of South and Central America Women Health Market by Product Type
12.5.8.3.2 Rest of South and Central America Women Health Market by Treatment Type
12.5.8.3.3 Rest of South and Central America Women Health Market by Diagnosis
12.5.8.3.4 Rest of South and Central America Women Health Market by Disease Indication
12.5.8.3.5 Rest of South and Central America Women Health Market by End-Users
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. WOMEN HEALTH MARKET, KEY COMPANY PROFILES
14.1. ELI LILLY AND COMPANY
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. AGILE THERAPEUTICS
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. PFIZER INC
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. MERCK SHARP AND DOHME CORP
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. FERRING B.V
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. AMGEN INC
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. MYLAN N.V. ( VIATRIS)
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. ABBOTT
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. F. HOFFMANN-LA ROCHE LTD
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. BLAIREX LABORATORIES, INC.
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies
- Eli Lilly and Company
- Agile Therapeutics
- Pfizer Inc
- Merck Sharp and Dohme Corp
- Ferring B.V
- Amgen Inc
- Mylan N.V. (Viatris)
- Abbott
- F. Hoffmann-La Roche Ltd
- Blairex Laboratories, Inc.
- Alembic Pharmaceuticals
- Sun Pharmaceutical Industries Limited
- Himalaya Wellness Company
- Glenmark
- Eli Lilly and Company
- Agile Therapeutics
- Pfizer Inc
- Merck Sharp and Dohme Corp
- Ferring B.V
- Amgen Inc
- Mylan N.V. (Viatris)
- Abbott
- F. Hoffmann-La Roche Ltd
- Blairex Laboratories, Inc.
- Alembic Pharmaceuticals
- Sun Pharmaceutical Industries Limited
- Himalaya Wellness Company
- Glenmark
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For